drugset / Trial / NCT07311772
Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
Phase 3
Recruiting
386 enrolled
Sun Yat-sen University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University · collabAffiliated Cancer Hospital of Shantou University Medical College · collabCancer Hospital Chinese Academy of Medical Science · collabCancer Hospital of Guangxi Medical University · collabEye & ENT Hospital of Fudan University · collabFirst Affiliated Hospital of Kunming Medical University · collabFujian Cancer Hospital · collabHunan Cancer Hospital · collabSun Yat-Sen University Cancer Center · collabThe Fifth Affiliated Hospital, Sun Yat-sen University · collabThe First People's Hospital of Changzhou · collabWest China Hospital · collabWuzhou Red Cross Hospital · collabXiangya Hospital of Central South University · collabYunnan Cancer Hospital · collabZhejiang Cancer Hospital · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
To explore the efficacy of Houyanqing Oral Liquid combined with conventional treatment in preventing and treating radiation-induced oral mucositis, so as to improve the quality of life of nasopharyngeal carcinoma patients received radiotherapy.
Timeline
- Start
- 2025-12-16
- Primary completion
- 2027-03-15
- Completion
- 2027-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Houyanqing Oral Liquid | Traditional medicine (herbal / TCM) | 10 ml | — |